Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials

INTRODUCTION: Bisphosphonates (BPs) are first-line therapy for osteoporosis. Adherence is usually low in chronic, asymptomatic diseases, but gastrointestinal (GI) side-effects can also contribute to low adherence in BP therapy and may necessitate a review by a gastroenterologist with or without gast...

Descripción completa

Detalles Bibliográficos
Autores principales: Dömötör, Zsuzsa Réka, Vörhendi, Nóra, Hanák, Lilla, Hegyi, Péter, Kiss, Szabolcs, Csiki, Endre, Szakó, Lajos, Párniczky, Andrea, Erőss, Bálint
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683730/
https://www.ncbi.nlm.nih.gov/pubmed/33240217
http://dx.doi.org/10.3389/fendo.2020.573976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683730/
https://www.ncbi.nlm.nih.gov/pubmed/33240217
http://dx.doi.org/10.3389/fendo.2020.573976

Ejemplares similares